Business Description
SQZ Biotechnologies Co
NAICS : 541714
SIC : 2833
ISIN : US78472W1045
Share Class Description:
SQZB: Ordinary SharesDescription
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.48 | |||||
| Equity-to-Asset | 0.06 | |||||
| Debt-to-Equity | 11.42 | |||||
| Debt-to-EBITDA | -0.44 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -23.03 | |||||
| Beneish M-Score | 0.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.2 | |||||
| 3-Year EBITDA Growth Rate | -10.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13 | |||||
| 3-Year FCF Growth Rate | -13.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.52 | |||||
| 9-Day RSI | 28.43 | |||||
| 14-Day RSI | 30.35 | |||||
| 6-1 Month Momentum % | 26.05 | |||||
| 12-1 Month Momentum % | -92.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 1.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.1 | |||||
| Shareholder Yield % | 5350.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -497.3 | |||||
| Net Margin % | -587.43 | |||||
| FCF Margin % | -611.24 | |||||
| ROE % | -186.28 | |||||
| ROA % | -86.98 | |||||
| ROIC % | -143.65 | |||||
| ROC (Joel Greenblatt) % | -189.23 | |||||
| ROCE % | -90.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.06 | |||||
| PB Ratio | 0.41 | |||||
| Price-to-Tangible-Book | 0.44 | |||||
| EV-to-EBIT | -0.2 | |||||
| EV-to-EBITDA | -0.25 | |||||
| EV-to-Revenue | 0.99 | |||||
| EV-to-Forward-Revenue | 0.4 | |||||
| EV-to-FCF | -0.16 | |||||
| Earnings Yield (Greenblatt) % | -500 | |||||
| FCF Yield % | -9532.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SQZB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SQZ Biotechnologies Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.196 | ||
| EPS (TTM) ($) | -2.43 | ||
| Beta | 0.21 | ||
| Volatility % | 161.3 | ||
| 14-Day RSI | 30.35 | ||
| 14-Day ATR ($) | 0.003166 | ||
| 20-Day SMA ($) | 0.041635 | ||
| 12-1 Month Momentum % | -92.48 | ||
| 52-Week Range ($) | 0.0101 - 0.65 | ||
| Shares Outstanding (Mil) | 29.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SQZ Biotechnologies Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SQZ Biotechnologies Co Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SQZ Biotechnologies Co Frequently Asked Questions
What is SQZ Biotechnologies Co(SQZB)'s stock price today?
The current price of SQZB is $0.03. The 52 week high of SQZB is $0.65 and 52 week low is $0.01.
When is next earnings date of SQZ Biotechnologies Co(SQZB)?
The next earnings date of SQZ Biotechnologies Co(SQZB) is 2024-08-09 Est..
Does SQZ Biotechnologies Co(SQZB) pay dividends? If so, how much?
SQZ Biotechnologies Co(SQZB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers